Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00999141 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy
A Phase 3 study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 75
- Enrollment target
NCT00999141 is a Phase 3 study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 75 participants.
The verdict
NCT00999141, a Phase 3 study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the safety and efficacy of FS VH S/D 4 s-apr versus standard of care in adhering tissue and improving wound healing in subjects undergoing facelift.
Interventions
- BIOLOGICAL FS VH S/D 4 s-apr
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00999141
The ClinicalTrials.gov registry entry for NCT00999141 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FS VH S/D 4 s-apr is the first listed.
NCT00999141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00999141 about?
NCT00999141 is a clinical study titled "Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy". The purpose of the study is to compare the safety and efficacy of FS VH S/D 4 s-apr versus standard of care in adhering tissue and improving wound healing in subjects undergoing facelift.
What is the current status of trial NCT00999141?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2009-09. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00999141?
The interventions under investigation include: FS VH S/D 4 s-apr (BIOLOGICAL).
Who is sponsoring clinical trial NCT00999141?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.